STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
590
13F, latest reported quarter
Conversions, 180 days
29
Codes C/M, not in net · $6.9M priced
What the filings say about VEEV
Insiders, 180 days
-$16.3M net sold
4 sellers · 38% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: purchase, 2025-05-29
Planned sales (Form 144), 90 days
$55.8M
10 notices
Veeva Systems insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, VEEVA SYSTEMS INC insiders sold a net $16.3M of stock across 291 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
13 earlier Form 4 trades (code P or S) here by this insider (13 sales), the last on Oct 6, 2025.
The trade is 60.5% of the 5,813 shares held after it.
2 other insiders sold within 30 days.
590 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Gen. Counsel, Secretary Faddis Jonathan sold about $1.1M of VEEV under a 10b5-1 plan on Oct 14, 2026; 2 other insiders sold within 30 days and 590 funds added in the latest 13F quarter.
13 earlier Form 4 trades (code P or S) here by this insider (13 sales), the last on Oct 6, 2025.
The trade is 20.2% of the 4,838 shares held after it.
2 other insiders sold within 30 days.
590 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Gen. Counsel, Secretary Faddis Jonathan sold about $291.8K of VEEV under a 10b5-1 plan on Oct 14, 2026; 2 other insiders sold within 30 days and 590 funds added in the latest 13F quarter.
13 earlier Form 4 trades (code P or S) here by this insider (13 sales), the last on Oct 6, 2025.
The trade is 17.1% of the 4,130 shares held after it.
2 other insiders sold within 30 days.
590 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Gen. Counsel, Secretary Faddis Jonathan sold about $211.1K of VEEV under a 10b5-1 plan on Oct 14, 2026; 2 other insiders sold within 30 days and 590 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 56.6% of the 7,986 shares held after it.
3 other insiders sold within 30 days.
590 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Sales, Consulting, & Svcs Rizzo Daniel J sold about $1.2M of VEEV on Oct 2, 2026; 3 other insiders sold within 30 days and 590 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 4.2% of the 7,665 shares held after it.
3 other insiders sold within 30 days.
590 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Sales, Consulting, & Svcs Rizzo Daniel J sold about $88.7K of VEEV on Oct 2, 2026; 3 other insiders sold within 30 days and 590 funds added in the latest 13F quarter.
291 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
VEEV planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
THOMAS SCHWENGER
Filed 2026-10-15
$745.5K
THOMAS SCHWENGER
Filed 2026-10-15
$900.0K
Faddis Jonathan
Filed 2026-10-14
$1.6M
THOMAS SCHWENGER
Filed 2026-10-14
$2.0M
THOMAS SCHWENGER
Filed 2026-10-05
$37.1M
VEEV mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Global X HealthTech ETF
$1.0M position · as of 2026-05-31
4.1%
Brown Capital Management Small Company Fund
$13.1M position · as of 2026-06-30
4.1%
iShares U.S. Healthcare Providers ETF
$46.9M position · as of 2026-06-30
4.0%
DF DENT MIDCAP GROWTH FUND
$8.5M position · as of 2026-06-30
3.7%
Hillman Value Fund
$2.5M position · as of 2026-06-30
3.2%
ERShares Private-Public Crossover ETF
$69.2M position · as of 2026-06-30
3.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Gassner
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$421.0K
$31.8M
$3.8M
+41%
-1%
2022
$392.0K
-$93.7M
$7.5M
+16%
+19%
2021
$350.0K
-$57.9M
$2.8M
+61%
+46%
2020
$346.0K
$326.1M
$2.5M
+89%
+32%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $16.3M sold by insiders over 180 days, 590 funds added last quarter, $55.8M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$3.5B
four quarters, 2025-08-01 to 2026-07-31
Revenue, TTM VEEV
FY Jan 2026
$3.2B
FY Jan 2025
$2.7B
FY Jan 2024
$2.4B
FY Jan 2023
$2.2B
FY Jan 2022
$1.9B
Jul 2026
$928.0M
Apr 2026
$882.9M
Jan 2026
$836.0M
Oct 2025
$811.2M
Jul 2025
$789.1M
Apr 2025
$759.0M
Jan 2025
$720.9M
Oct 2024
$699.2M
At each fiscal year end
Single quarter
Net margin, TTM
+29.3%
net income over revenue, 2025-08-01 to 2026-07-31
Net margin, TTM VEEV
FY Jan 2026
+28.4%
FY Jan 2025
+26.0%
FY Jan 2024
+22.2%
FY Jan 2023
+22.6%
FY Jan 2022
+23.1%
Jul 2026
+29.5%
Apr 2026
+29.6%
Jan 2026
+29.2%
Oct 2025
+29.1%
Jul 2025
+25.4%
Apr 2025
+30.1%
Jan 2025
+27.1%
Oct 2024
+26.6%
At each fiscal year end
Single quarter
Free cash flow, TTM
$1.7B
operating cash flow minus capex, 2025-08-01 to 2026-07-31
Free cash flow, TTM VEEV
FY Jan 2026
$1.4B
FY Jan 2025
$1.1B
FY Jan 2024
$909.7M
FY Jan 2023
$778.8M
FY Jan 2022
$762.8M
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity VEEV
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt VEEV
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+14.4%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on equity VEEV
FY Jan 2026
+13.9%
FY Jan 2025
+13.6%
FY Jan 2024
+12.6%
FY Jan 2023
+14.7%
FY Jan 2022
+16.5%
Jul 2026
+14.4%
Apr 2026
+13.9%
Jan 2026
+13.9%
Oct 2025
+13.7%
Jul 2025
+13.7%
Apr 2025
+14.1%
Jan 2025
+13.6%
Oct 2024
+13.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+11.9%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on assets VEEV
FY Jan 2026
+11.1%
FY Jan 2025
+10.8%
FY Jan 2024
+9.8%
FY Jan 2023
+11.3%
FY Jan 2022
+12.5%
Jul 2026
+11.9%
Apr 2026
+11.1%
Jan 2026
+11.1%
Oct 2025
+11.8%
Jul 2025
+11.3%
Apr 2025
+11.2%
Jan 2025
+10.8%
Oct 2024
+11.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
no debt line filed
Return on invested capital VEEV
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+14.4%
operating income (EBIT proxy) over average of 2025-07-31 and 2026-07-31 minus current liabilities
Return on capital employed VEEV
FY Jan 2026
+13.8%
FY Jan 2025
+13.0%
FY Jan 2024
+10.1%
FY Jan 2023
+13.6%
FY Jan 2022
+19.1%
Jul 2026
+14.4%
Apr 2026
+13.9%
Jan 2026
+13.8%
Oct 2025
+13.5%
Jul 2025
+13.3%
Apr 2025
+13.7%
Jan 2025
+13.0%
Oct 2024
+12.7%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
52.08x
close 2026-10-26 over four quarters of diluted EPS, 2025-08-01 to 2026-07-31
P/E, trailing VEEV
FY Jan 2026
37.49x
FY Jan 2025
54.00x
FY Jan 2024
64.41x
FY Jan 2023
56.66x
FY Jan 2022
89.94x
Jul 2026
33.35x
Apr 2026
27.65x
Jan 2026
37.49x
Oct 2025
56.76x
Jul 2025
58.48x
Apr 2025
49.62x
Jan 2025
54.00x
Oct 2024
51.56x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value VEEV
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+3.2%
TTM free cash flow over market value at close 2026-10-26
FCF yield VEEV
FY Jan 2026
+4.2%
FY Jan 2025
+2.9%
FY Jan 2024
+2.7%
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
+5.0%
Apr 2026
+6.5%
Jan 2026
+4.2%
Oct 2025
+2.9%
Jul 2025
+2.9%
Apr 2025
+3.2%
Jan 2025
+2.9%
Oct 2024
+3.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
2.02x
P/E over trailing EPS growth of 26%: four quarters to 2026-07-31 against the four to 2025-07-31
PEG, trailing VEEV
FY Jan 2026
1.45x
FY Jan 2025
1.58x
FY Jan 2024
9.23x
FY Jan 2023
3.92x
FY Jan 2022
7.86x
Jul 2026
1.30x
Apr 2026
1.40x
Jan 2026
1.45x
Oct 2025
2.13x
Jul 2025
1.98x
Apr 2025
1.27x
Jan 2025
1.58x
Oct 2024
3.15x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
VEEV ranks highest on institutional and government (94th percentile) and profitability (78th), and lowest on insider conviction (12th), among Software & IT peers.
Profitability
78
Inputs
Return on equity+14.4% · 71 pct, sector of 286
Return on assets+11.9% · 83 pct, sector of 381
Return on invested capitalno debt line filed
Return on capital employed+14.4% · 80 pct, sector of 294
Growth
64
Inputs
Revenue growth, YoY+16.3% · 64 pct, sector of 480
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
12
Inputs
Net Form 4 buying (codes P and S), 180d-$11.7M · 24 pct, sector of 285
Insider buyers, 180d0 · 0 pct, sector of 290
Institutional and government
94
Inputs
Funds adding, latest quarter590 · 94 pct, sector of 415
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
46
Inputs
Short interest, % of float+3.3% · 60 pct, sector of 530
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+15.4% · 33 pct, sector of 316
2 not measured: Financial health, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
VEEV filings, in plain words
Are Veeva Systems insiders buying or selling VEEV?
In the 180 days to 2026-10-27, Veeva Systems insiders were net sellers, a net $16.3M across purchases and sales reported on Form 4, by 4 sellers.
Have members of Congress traded VEEV?
Yes, but not in the year to 2026-10-27; the latest on record is a purchase by Rob Bresnahan dated 2025-05-29.
Are there planned insider sales of VEEV?
Yes. 10 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $55.8M of stock; the latest, by THOMAS SCHWENGER, was filed 2026-10-15.
Read the full summary
In the 180 days to 2026-10-27, Veeva Systems insiders were net sellers of VEEV, a net $16.3M across purchases and sales reported on Form 4 by 4 sellers. 38% of the 13 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Members of Congress have disclosed trades in VEEV, none in the last year; the latest on record is a purchase by Rob Bresnahan dated 2025-05-29. Insiders filed 10 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $55.8M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.